Unibios Holdings S.A. carries a market capitalization of 46.48M, placing it among publicly traded companies globally. Its enterprise value stands at 7.08M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 46.48M |
| Enterprise Value | 7.08M |
Unibios Holdings S.A. currently has 3.66M shares outstanding.
| Shares Outstanding | 3.66M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.19, and the price-to-book ratio stands at -0.14.
| PE Ratio | N/A |
| PS Ratio | 0.19 |
| PB Ratio | -0.14 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | 3.99 |
| P/OCF Ratio | 4.42 |
On an enterprise value basis, Unibios Holdings S.A. trades at an EV/EBITDA multiple of 61.60 and an EV/FCF ratio of 5.26. The EV/Sales ratio of 1.07 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 61.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.07 |
| EV / EBITDA | 61.60 |
| EV / EBIT | 61.60 |
| EV / FCF | 5.26 |
Unibios Holdings S.A. maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 57.07, indicating elevated leverage, while an interest coverage ratio of 0.28 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.12 |
| Quick Ratio | 0.11 |
| Debt / Equity | 57.07 |
| Debt / EBITDA | 54.99 |
| Interest Coverage | 0.28 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -2.26 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -0.78 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.11 |
Over the trailing twelve months, Unibios Holdings S.A. has paid 310,000.00 in income taxes, reflecting an effective tax rate of 11.76.
| Income Tax | 310,000.00 |
| Effective Tax Rate | 11.76 |
Unibios Holdings S.A.'s stock has gained approximately 28.70813% over the past 52 weeks. The 50-day moving average sits at 2.55, while the 200-day moving average is 2.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | 28.70813% |
| 50-Day Moving Average | 2.55 |
| 200-Day Moving Average | 2.73 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Unibios Holdings S.A. generated 6.61M in revenue and converted that into -520,000.00 in net income, yielding earnings per share of -0.14. EBITDA reached 115,000.00, while operating income came in at 115,000.00.
| Revenue | 6.61M |
| Gross Profit | 2.78M |
| Operating Income | 115,000.00 |
| Pretax Income | -204,000.00 |
| Net Income | -520,000.00 |
| EBITDA | 115,000.00 |
| EBIT | 115,000.00 |
| Earnings Per Share (EPS) | -0.14 |
Unibios Holdings S.A. holds 748,000.00 in cash and equivalents against 6.32M in total debt, resulting in a net debt position of 1.92M. Total book value stands at -8.94M, with working capital of 878,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 748,000.00 |
| Total Debt | 6.32M |
| Net Debt | 1.92M |
| Equity (Book Value) | -8.94M |
| Book Value Per Share | -2.43 |
| Working Capital | 878,000.00 |
Unibios Holdings S.A. produced 290,000.00 in operating cash flow over the past twelve months. After subtracting -31,000.00 in capital expenditures, free cash flow totaled 259,000.00 - equivalent to 0.07 per share.
| Operating Cash Flow | 290,000.00 |
| Capital Expenditures | -31,000.00 |
| Free Cash Flow | 259,000.00 |
| FCF Per Share | 0.07 |
Unibios Holdings S.A. operates with a gross margin of 42.08, reflecting its pricing power and cost economics. The operating margin of 1.74 and net profit margin of -7.87 provide insight into operational efficiency.
| Gross Margin | 42.08 |
| Operating Margin | 1.74 |
| Pretax Margin | -3.09 |
| Profit Margin | -7.87 |
| EBITDA Margin | 1.74 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -28.87 |
| FCF Yield | 25.05 |
Unibios Holdings S.A.'s most recent stock split took place on July 24, 2019 with a 500:589 split ratio.
| Last Split Date | 7/24/2019 |
| Split Ratio | 500:589 |
Unibios Holdings S.A. posts an Altman Z-Score of -0.67, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.67 |